Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · IEX Real-Time Price · USD
1.400
-0.020 (-1.41%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Spero Therapeutics Market Cap
Spero Therapeutics has a market cap or net worth of $75.58 million as of July 22, 2024. Its market cap has increased by 0.51% in one year.
Market Cap
75.58M
Enterprise Value
-1.45M
1-Year Change
0.51%
Ranking
Category
Stock Price
$1.40
Market Cap Chart
Since November 2, 2017, Spero Therapeutics's market cap has decreased from $154.10M to $75.58M, a decrease of -50.95%. That is a compound annual growth rate of -10.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 75.60M | -2.95% |
| Dec 29, 2023 | 77.90M | -13.06% |
| Dec 30, 2022 | 89.60M | -82.69% |
| Dec 31, 2021 | 517.50M | -1.84% |
| Dec 31, 2020 | 527.20M | 186.68% |
| Dec 31, 2019 | 183.90M | 64.34% |
| Dec 31, 2018 | 111.90M | -33.71% |
| Dec 29, 2017 | 168.80M | 9.54% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| T2 Biosystems | 77.91M |
| SHL Telemedicine | 77.45M |
| MDxHealth | 76.41M |
| Eagle Pharmaceuticals | 76.23M |
| Genelux | 75.92M |
| enVVeno Medical | 75.45M |
| Kronos Bio | 75.12M |
| Cognition Therapeutics | 73.71M |